Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

Ovarian cancer is challenging due to late-stage detection. Understanding genetic risk factors and family history can aid in ...

Ask yourself how the genetic test results may affect your life. If the results come back positive, will you take steps to ...

Drug resistance to doxorubicin is mediated through the ABCG2 protein by the TMEM158 gene.ABCG2 protein ( ATP-binding cassette sub-family G member. Is an efflux pump protein that actively transports ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

A molar pregnancy, also known as a hydatidiform mole, is an abnormal human pregnancy with no embryo and an overgrowth of the ...

Nuvectis Pharma (NVCT) stock falls as company posts interim data from a Phase 1b trial for its ovarian cancer drug candidate.

A simple blood test could soon predict which ovarian cancer patients will stop responding to their treatment, paving the way ...

The NHS is set to help find thousands of volunteers for a Yorkshire Cancer Research-funded genetic screening clinical trial.

The Ovarian Cancer Research Alliance offers specialized services and support to help ovarian cancer patients find a community ...

Penn Ovarian Cancer Research Center and Basser Center for BRCA, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States ...

Daly, MD, PhD, FACP, Fox Chase Cancer Center, Chair of the NCCN Guidelines Panel for Genetic/Familial High-Risk Assessment: ...